A ressonância magnética cardíaca (RMC) é uma técnica sem radiação, considerada padrão para avaliação da anatomia, função e até composição do tecido cardíaco. O estudo RESILIENCE usará a RMC como a principal metodologia para medir os resultados da intervenção e os doentes inscritos no estudo serão submetidos a três exames ao longo da duração do estudo.
Ensaio clínico multinacional, prospectivo, de prova de conceito, de fase II com dupla ocultação, controlado com simulação, aleatorizado (RCT) para avaliar a eficácia e segurança do Condicionamento Isquémico Remoto (RIC) em doentes com linfoma não Hodgkin (LNH) que são tratados com antraciclinas. Os doentes programados para receberem pelo menos 5 ciclos de quimioterapia com antraciclinas são elegíveis para participar no estudo.
Clinical trials are essential for advancing medicine. Thanks to them, today we now have safer, more effective, and increasingly personalized treatments. However, for many people, participating in a clinical trial naturally raises questions: What does participation involve? How does the process unfold? What kind of follow‑up is provided? At RESILIENCE,
Early detection of cardiac damage is one of the most effective tools to prevent cardiovascular complications, improve prognosis, and preserve quality of life. Identifying alterations in the heart before symptoms appear allows for early intervention, treatment adjustments, and protection of cardiovascular health in both the short and long term. This
December arrives each year with the perfect blend of excitement, celebrations, and long-awaited reunions. These are days to share, enjoy, and create memories with those we love most. At the same time, it is also a season when our habits tend to change: richer meals, more alcohol than usual, less
Autumn brings shorter days, cooler temperatures that invite for warm clothing, and a routine that sometimes sets the pace again. This season often fosters a sense of tranquility; however, it may also be accompanied by increased fatigue, emotional fluctuations, or elevated stress levels. For those going through an oncological process,
Cardiovascular research has just taken a huge step forward. The REBOOT clinical trial, led by the Spanish National Center for Cardiovascular Research (CNIC) in collaboration with the Mario Negri Institute in Milan, has shown that a medical practice in place for more than 40 years may no longer be necessary
Cancer, along with cardiovascular diseases, is among the leading causes of mortality worldwide. In Spain, it ranks first in both incidence and number of deaths. However, it is estimated that only between 5% and 10% of cases are genetic or hereditary. The remaining cases are associated with environmental factors and
